In the absence of data for each cancer type, some inputs were based on studies that examined patients with different cancer types, including the RR of an FN event where it was assumed that the RR for NHL and NSCLC was the same as for BC and self-administration of G-CSF was assumed to be the same across all cancers in the absence of cancer-specific data. This evidence concerns the gene CSF3 and non-Hodgkin lymphoma.